Additionally, lncRNA PEBP1P2 has also presented beneficial protective effects against abnormal VSCM proliferation and atherosclerosis, mainly by targeting the cyclin-dependent kinase 9 (CDK9) pathway. The gene discussed is CDK9; the disease is atherosclerosis.